Join the club for FREE to access the whole archive and other member benefits.

Oxford Immune Algorithmics (OIA)

Applying Artificial General Intelligence to deliver decentralised precision health and predictive medicine

Oxford Immune Algorithmics (OIA) is an award-winning Bio and MedTech company incubated by the University of Oxford, now operating multinationally, which builds technology to move healthcare away from its reliance on population-wide symptom pattern matching toward value-based precision medicine and personalised diagnostics.

Algocyte is OIA’s suite of end-to-end AGI-driven solutions that enable remote digital endpoints in healthcare pathways to monitor people’s health from their own homes through minimally invasive intelligent testing, collection, and analysis of multimodal data streams including clinical and lifestyle. 

The team exploits its research experience carried out at top-ranked institutions at the forefront of AI and medicine, including Oxford, Cambridge, and Karolinska. OIA’s founders have published more than 200 papers in all the top-ranked journals in the areas of Artificial Intelligence, computational medicine, and systems immunology.

Oxford Immune Algorithmics (OIA) Board

• Hector Zenil - Founder and Chief Visionary Officer

• Pamela Winsor

• Allan Bezanson

• Jesper N. Tegnér

Oxford Immune Algorithmics (OIA) Leadership

• Michelle Lea

• Kourosh Saeb-Parsy

• Alfonso Ferrandez

Visit website:




Details last updated 08-Oct-2023

Mentioned in this Resource

Alfonso Ferrandez

Chief Technology Officer at Oxford Immune Algorithmics

Allan Bezanson

Chair at BW Founders Holdings and Director at Oxford Immune Algorithmics

Hector Zenil

Founder and Chief Visionary Officer at Oxford Immune Algorithmics (OIA)

Jesper Tegner

Professor of Bioscience and Computer Science at King Abdullah University of Sciences and Technology, Director at OIA

Kourosh Saeb-Parsy

Professor of Transplantation, Laboratory & Clinical Research Group Leader at the University of Cambridge

Michelle Lea

Chief Executive Officer at Oxford Immune Algorithmics

Pamela Winsor

Former CMO of Medtronic Canada, Chair at Oxford Immune Algorithmics (OIA)

Oxford Immune Algorithmics (OIA) Blog Posts

Oxford Immune Algorithmics developing AI-driven precision medicine for all – site visit report

Oxford Immune Algorithmics developing AI-driven precision medicine for all – site visit report

Algocyte platform uses algorithmic inverse problem solving to aid clinicians in their diagnosis

Oxford Immune Algorithmics (OIA) News

Oxford's OIA advances healthcare with their revolutionary platform, Algocyte - 13-Sep-2023

Algocyte integrates data for personalised precision medicine

Topics mentioned on this page:
Precision Medicine, Medical Technology